RLMD - RELMADA THERAPEUTICS, INC.

QQQ $ 627.30 $ 0.00 (0 %)

DIA $ 474.31 $ -0.58 (-0.12 %)

SPY $ 683.89 $ 1.12 (0.16 %)

TLT $ 91.61 $ 0.30 (0.33 %)

GLD $ 368.77 $ -2.23 (-0.6 %)

Previous Close

$ 2.1

Open

$ 2.26

Bid

$ 2.29 x 101

Ask

$ 2.32 x 550

Day's Range

$ 2.28 - $ 2.40

52 Week Range

$ 0.24 - $ 3.98

Volume

103,260

Average Volume

Market Cap

69.7M

Beta (5Y Monthly)

$ 1.43

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2025	06-30-2025	10-Q
2	05-12-2025	03-31-2025	10-Q
3	03-27-2025	12-31-2024	10-K
4	11-07-2024	09-30-2024	10-Q
5	08-07-2024	06-30-2024	10-Q
6	05-08-2024	03-31-2024	10-Q
7	03-19-2024	12-31-2023	10-K
8	11-08-2023	09-30-2023	10-Q
9	08-08-2023	06-30-2023	10-Q
10	05-11-2023	03-31-2023	10-Q
11	03-23-2023	12-31-2022	10-K
12	11-10-2022	09-30-2022	10-Q
13	08-11-2022	06-30-2022	10-Q
14	05-05-2022	03-31-2022	10-Q
15	03-25-2022	12-31-2021	10-K
16	11-12-2021	09-30-2021	10-Q
17	08-10-2021	06-30-2021	10-Q
18	05-12-2021	03-31-2021	10-Q
19	03-24-2021	12-31-2020	10-K
20	11-12-2020	09-30-2020	10-Q
21	08-12-2020	06-30-2020	10-Q
22	05-15-2020	03-31-2020	10-Q
23	11-13-2019	09-30-2019	10-Q
24	09-24-2019	06-30-2019	10-K
25	05-15-2019	03-31-2019	10-Q
26	02-13-2019	12-31-2018	10-Q
27	11-13-2018	09-30-2018	10-Q
28	09-28-2018	06-30-2018	10-K
29	05-14-2018	03-31-2018	10-Q
30	02-12-2018	12-31-2017	10-Q
31	11-14-2017	09-30-2017	10-Q
32	09-28-2017	06-30-2017	10-K
33	05-15-2017	03-31-2017	10-Q
34	02-10-2017	12-31-2016	10-Q
35	11-10-2016	09-30-2016	10-Q
36	09-09-2016	06-30-2016	10-K
37	05-09-2016	03-31-2016	10-Q
38	02-05-2016	12-31-2015	10-Q
39	11-06-2015	09-30-2015	10-Q
40	09-11-2015	06-30-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12 Health Care Stocks Moving In Monday's I...
10/06/2025 17:07:04

12 Health Care Stocks Moving In Friday's I...
10/03/2025 17:06:08

Relmada Regains Compliance With Nasdaq $1 ...
09/16/2025 13:05:17

Relmada CEO Sergio Traversa Reports 91% Co...
09/10/2025 11:18:38

12 Health Care Stocks Moving In Thursday's...
09/04/2025 21:13:45

12 Health Care Stocks Moving In Tuesday's ...
09/02/2025 17:06:49

Relmada Therapeutics CMO Raj S. Pruthi Pur...
09/02/2025 15:40:12

On August 29, 2025, Raj S. Pruthi, MD, Chief Medical Officer-Urology of Relmada Therapeutics, Inc. (the "Company"), pur...

12 Health Care Stocks Moving In Friday's I...
08/29/2025 17:05:57

12 Health Care Stocks Moving In Friday's P...
08/29/2025 12:07:49

12 Health Care Stocks Moving In Thursday's...
08/28/2025 21:06:27

Relmada Therapeutics Q2 EPS $(0.30) Misses...
08/07/2025 20:07:15

Relmada Therapeutics (NASDAQ:RLMD) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate o...

Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

why-medpace-shares-are-trading-higher-by-45-here-are-20-stocks-moving-premarket

Why Medpace Shares Are Trading Higher By 4...
07/22/2025 09:39:38

Relmada Therapeutics Terminates License Ag...
07/10/2025 20:57:14

-SEC Filing

Relmada Therapeutics Q1 GAAP EPS $(0.58) M...
05/12/2025 20:06:05

Relmada Therapeutics (NASDAQ:RLMD) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate o...

Earnings Scheduled For May 12, 2025
05/12/2025 08:32:31

12 Health Care Stocks Moving In Tuesday's ...
04/29/2025 17:06:04

12 Health Care Stocks Moving In Tuesday's ...
04/29/2025 12:07:23

12 Health Care Stocks Moving In Monday's A...
04/28/2025 21:05:47

Relmada Therapeutics: Initial Data From Ph...
04/28/2025 17:44:22

90% of patients achieved high grade disease-free status at any time point with NDV-01, demonstrating strong proof-of-concept fo...